Downregulation of 14-3-3β inhibits proliferation and migration in osteosarcoma cells

Wu,Quanming; Zhu,Jianwei; Liu,Fan; Liu,Jin; Li,Mingpeng

doi:10.3892/mmr.2017.8144

Downregulation of 14-3-3β inhibits proliferation and migration in osteosarcoma cells

Authors:
- Quanming Wu
- Jianwei Zhu
- Fan Liu
- Jin Liu
- Mingpeng Li
View Affiliations

Affiliations: Department of Orthopedics, The Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China
Published online on: November 22, 2017 https://doi.org/10.3892/mmr.2017.8144
Pages: 2493-2500

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The 14-3-3 protein isoform β (14‑3‑3β), which is an intracellular adaptor protein that exists in all eukaryotic organisms, is highly expressed in many cancer tissues, including glioma, lung carcinoma and breast cancer. However, 14‑3‑3β expression and function in osteosarcoma progression remain unknown. In the present study, the endogenous expression of 14‑3‑3β was assessed in osteosarcoma samples and the effect of 14‑3‑3β knockdown was examined in human osteosarcoma MG63 cells using small interfering RNA (siRNA). mRNA and protein expression levels for 14‑3‑3β were detected by reverse transcription‑quantitative polymerase reaction and western blotting, respectively. The results demonstrated that endogenous 14‑3‑3β mRNA and protein were highly expressed in human osteosarcoma tissues and osteosarcoma cell lines (U2OS, MG63 and SaOs‑2), but not in normal bone tissues or normal osteoblast hFOB1.19 cells. These data suggested that increased expression of 14‑3‑3β may be significantly associated with the development and progression of osteosarcoma. Therefore, the effect of 14‑3‑3β knockdown in MG63 cells was further examined in vitro. Knockdown of 14‑3‑3β by siRNA significantly decreased cell viability, and inhibited cell proliferation and invasion. In addition, 14‑3‑3β knockdown significantly decreased the protein expression levels of β‑catenin, cyclin D1, v‑myc avian myelocytomatosis viral oncogene homolog and matrix metallopeptidase 9 in osteosarcoma MG63 cells. These results suggested that the anticancer effects of 14‑3‑3β knockdown in MG63 cells might be mediated by the inhibition of the Wnt/β‑catenin signaling pathway. In summary, 14‑3‑3β knockdown decreased proliferation and invasion in MG63 cells, which suggests a potential therapeutic application for 14‑3‑3β as a novel target for the treatment of osteosarcoma patients.

View Figures

View References

1	Wan J and Zhang X, Liu T and Zhang X: Strategies and developments of immunotherapies in osteosarcoma. Oncol Lett. 11:511–520. 2016.PubMed/NCBI
2	Endo-Munoz L, Evdokiou A and Saunders NA: The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis. Biochim Biophys Acta. 1826:434–442. 2012.PubMed/NCBI
3	Lamora A, Talbot J, Bougras G, Amiaud J, Leduc M, Chesneau J, Taurelle J, Stresing V, Le Deley MC, Heymann MF, et al: Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma. Clin Cancer Res. 20:5097–5112. 2014. View Article : Google Scholar : PubMed/NCBI
4	Poletajew S, Fus L and Wasiutyński A: Current concepts on pathogenesis and biology of metastatic osteosarcoma tumors. Ortop Traumatol Rehabil. 13:537–545. 2011.(In English, Polish). View Article : Google Scholar : PubMed/NCBI
5	Yang X, Cao W, Lin H, Zhang W, Lin W, Cao L, Zhen H, Huo J and Zhang X: Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J Neurol Sci. 276:54–59. 2009. View Article : Google Scholar : PubMed/NCBI
6	Freeman AK and Morrison DK: 14-3-3 Proteins: Diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol. 22:681–687. 2011. View Article : Google Scholar : PubMed/NCBI
7	Tzivion G, Gupta VS, Kaplun L and Balan V: 14-3-3 proteins as potential oncogenes. Semin Cancer Biol. 16:203–213. 2006. View Article : Google Scholar : PubMed/NCBI
8	Niemantsverdriet M, Wagner K, Visser M and Backendorf C: Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene. 27:1315–1319. 2008. View Article : Google Scholar : PubMed/NCBI
9	Lee CH, Ou WB, Mariño-Enriquez A, Zhu M, Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, et al: 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci USA. 109:pp. 929–934. 2012; View Article : Google Scholar : PubMed/NCBI
10	Qi W, Liu X, Qiao D and Martinez JD: Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer. 113:359–363. 2005. View Article : Google Scholar : PubMed/NCBI
11	Liu Y, Tian RF, Li YM, Liu WP, Cao L, Yang XL, Cao WD and Zhang X: The expression of seven 14-3-3 isoforms in human meningioma. Brain Res. 1336:98–102. 2010. View Article : Google Scholar : PubMed/NCBI
12	Wilker EW, van Vugt MA, Artim SA, Huang PH, Petersen CP, Reinhardt HC, Feng Y, Sharp PA, Sonenberg N, White FM and Yaffe MB: 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature. 446:329–332. 2007. View Article : Google Scholar : PubMed/NCBI
13	Sun N, Wu Y, Huang B, Liu Q, Dong Y, Ding J and Liu Y: Decreased expression of 14-3-3 σ, an early event of malignant transformation of respiratory epithelium, also facilitates progression of squamous cell lung cancer. Thorac Cancer. 6:715–721. 2015. View Article : Google Scholar : PubMed/NCBI
14	Radhakrishnan VM, Putnam CW, Qi W and Martinez JD: P53 suppresses expression of the 14-3-3 gamma oncogene. BMC Cancer. 11:3782011. View Article : Google Scholar : PubMed/NCBI
15	Mulvey HE, Chang A, Adler J, Del Tatto M, Perez K, Quesenberry PJ and Chatterjee D: Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells. BMC Cancer. 15:5712015. View Article : Google Scholar : PubMed/NCBI
16	Li N, Wang H, Fan J, Tong C, Yang J, Wei H, Yi J and Ling R: Overexpression of 14-3-3θ promotes tumor metastasis and indicates poor prognosis in breast carcinoma. Oncotarget. 5:249–257. 2014. View Article : Google Scholar : PubMed/NCBI
17	Liu TA, Jan YJ, Ko BS, Chen SC, Liang SM, Hung YL, Hsu C, Shen TL, Lee YM, Chen PF, et al: Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. Am J Pathol. 179:2698–2708. 2011. View Article : Google Scholar : PubMed/NCBI
18	Tang Y, Lv P, Sun Z, Han L and Zhou W: 14-3-3β promotes migration and invasion of human hepatocellular carcinoma cells by modulating expression of MMP2 and MMP9 through PI3K/Akt/NF-κB pathway. PLoS One. 11:e01460702016. View Article : Google Scholar : PubMed/NCBI
19	Gong F, Wang G, Ye J, Li T, Bai H and Wang W: 14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway. Oncol Rep. 30:2976–2982. 2013. View Article : Google Scholar : PubMed/NCBI
20	Takihara Y, Matsuda Y and Hara J: Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis. 21:2073–2077. 2000. View Article : Google Scholar : PubMed/NCBI
21	Wang Z, Nesland JM, Suo Z, Trope CG and Holm R: The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3β and ε are independent prognostic factors for these tumors. PLoS One. 6:e248432011. View Article : Google Scholar : PubMed/NCBI
22	Zhu J, Liu F, Wu Q and Liu X: Activin A regulates proliferation, invasion and migration in osteosarcoma cells. Mol Med Rep. 11:4501–4507. 2015. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Kim JO, Kim SR, Lim KH, Kim JH, Ajjappala B, Lee HJ, Choi JI and Baek KH: Deubiquitinating enzyme USP37 regulating oncogenic function of 14-3-3γ. Oncotarget. 6:36551–36576. 2015.PubMed/NCBI
25	Wu YJ, Jan YJ, Ko BS, Liang SM and Liou JY: Involvement of 14-3-3 proteins in regulating tumor progression of hepatocellular carcinoma. Cancers (Basel). 7:1022–1036. 2015. View Article : Google Scholar : PubMed/NCBI
26	Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, et al: EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Res. 71:4028–4039. 2011. View Article : Google Scholar : PubMed/NCBI
27	Stewart DJ: Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014. View Article : Google Scholar : PubMed/NCBI
28	Cao L, Lei H, Chang MZ, Liu ZQ and Bie XH: Down-regulation of 14-3-3β exerts anti-cancer effects through inducing ER stress in human glioma U87 cells: Involvement of CHOP-Wnt pathway. Biochem Biophys Res Commun. 462:389–395. 2015. View Article : Google Scholar : PubMed/NCBI
29	Chen H, Liu L, Ma B, Ma TM, Hou JJ, Xie GM, Wu W, Yang FQ and Chen YG: Protein kinase A-mediated 14-3-3 association impedes human Dapper1 to promote dishevelled degradation. J Biol Chem. 286:14870–14880. 2011. View Article : Google Scholar : PubMed/NCBI
30	Ma Y, Li YF, Wang T, Pang R, Xue YW and Zhao SP: Identification of proteins associated with lymph node metastasis of gastric cancer. J Cancer Res Clin Oncol. 140:1739–1749. 2014. View Article : Google Scholar : PubMed/NCBI
31	Okayama A, Miyagi Y, Oshita F, Nishi M, Nakamura Y, Nagashima Y, Akimoto K, Ryo A and Hirano H: Proteomic analysis of proteins related to prognosis of lung adenocarcinoma. J Proteome Res. 13:4686–4694. 2014. View Article : Google Scholar : PubMed/NCBI
32	Cai J, Feng D, Hu L, Chen H, Yang G, Cai Q, Gao C and Wei D: FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling. Br J Cancer. 113:1720–1729. 2015. View Article : Google Scholar : PubMed/NCBI
33	Ye GD, Sun GB, Jiao P, Chen C, Liu QF, Huang XL, Zhang R, Cai WY, Li SN and Wu JF: OVOL2, an inhibitor of WNT signaling, reduces invasive activities of human and mouse cancer cells and is down-regulated in human colorectal tumors. Gastroenterology. 150:659–671.e16. 2016. View Article : Google Scholar : PubMed/NCBI
34	Fan Y and Guo Y: Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway. Int J Clin Exp Pathol. 8:10420–10427. 2015.PubMed/NCBI
35	Deng Z, Wang L, Hou H, Zhou J and Li X: Epigenetic regulation of IQGAP2 promotes ovarian cancer progression via activating Wnt/β-catenin signaling. Int J Oncol. 48:153–160. 2015.PubMed/NCBI